As the costs of health care continue to increase, insurance reimbursements have become even more important for medical institutions to sustain their practices and expand optimal services.
In fall 2021, staffers at Johnson Memorial Health were hoping they could finally catch their breath. They were just coming out of a weeks-long surge of covid-19 hospitalizations and deaths, fueled by the delta variant.
Oncology leaders testified before a House subcommittee about how drug shortages are hindering cancer care in the US and threatening the lives of patients.
Researchers sought to create patient-derived iPSC models that represent all major genetic classes of human acute myeloid leukemia, including the survival rate.
Erica Johnson, MD, discusses strategies to combat health misinformation in the wake of updates released by the CDC on recommendations for COVID-19 vaccination.
Researchers sought to determine the considerations needed for patients with chronic myeloid leukemia who conceive or wish to become pregnant while receiving TKI therapy.
Researchers sought to better discriminate true MRD positivity for risk stratification in chronic lymphocytic leukemia and acute lymphoblastic leukemia in children.
Researchers are conducting phase 2 trials to assess various combination therapies, including BCMA, in patents with relapsed/refractory multiple myeloma.
Research presented at the 2023 Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR demonstrated favorable results for various types of lymphoma.
A central objective of addressing moral distress is to permit clinicians to effectively perform their professional functions and thus better help patients.
The phase 3 PhALLCON trial showed a trend toward improved EFS in patients with Ph+ newly diagnosed ALL when treated with ponatinib compared with imatinib.
Addressing moral distress means not just obtaining ethics consultation as needed but also dealing with the feeling of powerlessness that often accompanies it.
Researchers sought to determine whether there were delays in or discontinuation of treatment for cancer among different populations during the COVID-19 pandemic.
AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.
AML research presented at ASH 2022 highlighted promising combination regimens and suggested that some patients may benefit from less intensive treatment.